Trial Profile
Effect of IL-4RαR576 Polymorphism on Response to Dupilumab in Asthma, a Genotype-stratified, Randomized, Placebo- Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2024
Price :
$35
*
At a glance
- Drugs Dupilumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms IDEA
- 09 Nov 2023 Planned End Date changed from 1 Mar 2024 to 1 Mar 2027.
- 09 Nov 2023 Planned primary completion date changed from 1 Sep 2023 to 1 Sep 2026.
- 03 Nov 2021 Status changed from not yet recruiting to recruiting.